At a glance
- Originator Cayman Chemical; Taisho Pharmaceutical
- Developer Taisho Pharmaceutical
- Class Antipyretics; Nitrobenzenes; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Inflammation; Renal colic